Yield10 Bioscience Inc expected to post a loss of 63  cents a share - Earnings Preview

Yield10 Bioscience

07/03/2022 22:51

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 9. 
    * The Woburn Massachusetts-based  company is expected to
report  a
50.0% decrease in revenue to $97.5 thousand from $195 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Yield10 Bioscience
Inc is
for a loss of 63 cents per share. For the same quarter last
year, the company reported a loss of 79 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $21.5​, about 75.6% above​ its last closing
price of $5.24. ​​​

This summary was machine generated March 7 at 22:51 GMT.  All
figures in US dollars  unless otherwise stated